Lorenzo Magenta
Immunogenicity of High-Dose vs. MF59-adjuvanted vs. Standard Influenza Vaccine in Solid Organ Transplant Recipients: The STOP-FLU trial.
Mombelli M, Neofytos D, Huynh-Do U, Sánchez-Céspedes J, Stampf S, Golshayan D, Dahdal S, Stirnimann G, Schnyder A, Garzoni C, Venzin R, Magenta L, Schönenberger M, Walti L, Hirzel C, Munting A, Dickenmann M, Koller M, Aubert J, Steiger J, Pascual M, Müller T, Schuurmans M, Berger C, Binet F, Villard J, Müller N, Egli A, Cordero E, Van Delden C, Manuel O, Swiss Transplant Cohort Study. Immunogenicity of High-Dose vs. MF59-adjuvanted vs. Standard Influenza Vaccine in Solid Organ Transplant Recipients: The STOP-FLU trial. Clin Infect Dis 2023
Aug 16, 2023Immunogenicity of High-Dose vs. MF59-adjuvanted vs. Standard Influenza Vaccine in Solid Organ Transplant Recipients: The STOP-FLU trial.
Aug 16, 2023Clin Infect Dis 2023
Mombelli Matteo, Neofytos Dionysios, Huynh-Do Uyen, Sánchez-Céspedes Javier, Stampf Susanne, Golshayan Délaviz, Dahdal Suzan, Stirnimann Guido, Schnyder Aurelia, Garzoni Christian, Venzin Reto M, Magenta Lorenzo, Schönenberger Melanie, Walti Laura N, Hirzel Cédric, Munting Aline, Dickenmann Michael, Koller Michael, Aubert John-David, Steiger Jürg, Pascual Manuel, Müller Thomas F, Schuurmans Macé M, Berger Christoph T, Binet Françoise-Isabelle, Villard Jean, Müller Nicolas J., Egli Adrian, Cordero Elisa, Van Delden Christian, Manuel Oriol, Swiss Transplant Cohort Study
Real-world effectiveness and safety of glecaprevir/pibrentasvir therapy in patients with chronic hepatitis C virus infection in Switzerland
Mullhaupt B, Semela D, Ruckstuhl L, Magenta L, Clerc O, Torgler R, Negro F, Semmo N. Real-world effectiveness and safety of glecaprevir/pibrentasvir therapy in patients with chronic hepatitis C virus infection in Switzerland. Swiss Med Wkly 2021; 151:w20399.
Jan 19, 2021Real-world effectiveness and safety of glecaprevir/pibrentasvir therapy in patients with chronic hepatitis C virus infection in Switzerland
Jan 19, 2021Swiss Med Wkly 2021; 151:w20399
Mullhaupt Beat, Semela David, Ruckstuhl Lisa, Magenta Lorenzo, Clerc Olivier, Torgler Ralph, Negro Francesco, Semmo Nasser
A prospective, multicenter, post-marketing observational study to measure the quality of life of HCV genotype 1 infected, treatment naïve patients suffering from fatigue and receiving 3D regimen: The HEMATITE study
Semmo N, Mullhaupt B, Ruckstuhl L, Magenta L, Clerc O, Torgler R, Semela D. A prospective, multicenter, post-marketing observational study to measure the quality of life of HCV genotype 1 infected, treatment naïve patients suffering from fatigue and receiving 3D regimen: The HEMATITE study. PloS one 2020; 15:e0241267.
Nov 4, 2020A prospective, multicenter, post-marketing observational study to measure the quality of life of HCV genotype 1 infected, treatment naïve patients suffering from fatigue and receiving 3D regimen: The HEMATITE study
Nov 4, 2020PloS one 2020; 15:e0241267
Semmo Nasser, Mullhaupt Beat, Ruckstuhl Lisa, Magenta Lorenzo, Clerc Olivier, Torgler Ralph, Semela David
Excellent outcome of direct antiviral treatment for chronic hepatitis C in Switzerland
Bachofner J, Mertens J, Terziroli Beretta-Piccoli B, Mullhaupt B, Magenta L, Semela D, Fehr J, Moncsek A, Seifert B, Braun D, Baserga A, Künzler-Heule P, Kröger A, Bergamin I, Valli P, The Swiss Hepatitis C Cohort Study. Excellent outcome of direct antiviral treatment for chronic hepatitis C in Switzerland. Swiss Med Wkly 2018; 148:w14560.
Jan 18, 2018Excellent outcome of direct antiviral treatment for chronic hepatitis C in Switzerland
Jan 18, 2018Swiss Med Wkly 2018; 148:w14560
Bachofner Jacqueline, Mertens Joachim, Terziroli Beretta-Piccoli Benedetta, Mullhaupt Beat, Magenta Lorenzo, Semela David, Fehr Jan, Moncsek Anja, Seifert Burkhardt, Braun Dominique L, Baserga Adriana, Künzler-Heule Patrizia, Kröger Arne, Bergamin Irina, Valli Piero V, The Swiss Hepatitis C Cohort Study
Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis
De Gottardi A, Nery F, Deltenre P, Turon F, Engelmann C, Arya R, Caca K, Peck-Radosavljevic M, Leebeek F, Valla D, Garcia-Pagan J, Navascuès C, Mullhaupt B, Puente A, Trebicka J, Klinger C, Plessier A, Seijo S, Terziroli B, Magenta L, Semela D, Buscarini E, Langlet P, Görtzen J. Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis. Liver Int 2016
Oct 25, 2016Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis
Oct 25, 2016Liver Int 2016
De Gottardi Andrea, Nery Filipe, Deltenre Pierre, Turon Fanny, Engelmann Cornelius, Arya Rupen, Caca Karel, Peck-Radosavljevic Markus, Leebeek Frank W G, Valla Dominique, Garcia-Pagan Juan Carlos, Navascuès Carmen, Mullhaupt Beat, Puente Angela, Trebicka Jonel, Klinger Christoph, Plessier Aurélie, Seijo Susana, Terziroli Benedetta, Magenta Lorenzo, Semela David, Buscarini Elisabetta, Langlet Philippe, Görtzen Jan
DAA treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers FIB-4 and APRI
Bachofner J, Mullhaupt B, Terziroli Beretta-Piccoli B, Magenta L, Semela D, Fehr J, Moncsek A, Seifert B, Braun D, Baserga A, Künzler-Heule P, Bergamin I, Kröger A, Valli P, Mertens J. DAA treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers FIB-4 and APRI. Liver Int 2016
Sep 28, 2016DAA treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers FIB-4 and APRI
Sep 28, 2016Liver Int 2016
Bachofner Jacqueline A, Mullhaupt Beat, Terziroli Beretta-Piccoli Benedetta, Magenta Lorenzo, Semela David, Fehr Jan, Moncsek Anja, Seifert Burkhardt, Braun Dominique, Baserga Adriana, Künzler-Heule Patrizia, Bergamin Irina, Kröger Arne, Valli Piero V, Mertens Joachim C
Small dense lipoproteins, apolipoprotein B, and risk of coronary events in HIV-infected patients on antiretroviral therapy: the Swiss HIV Cohort Study
Bucher H, Battegay M, Furrer H, Weber R, Hirschel B, Vernazza P, Cavassini M, Wang Q, Magenta L, Glass T, Richter W, Bernasconi E. Small dense lipoproteins, apolipoprotein B, and risk of coronary events in HIV-infected patients on antiretroviral therapy: the Swiss HIV Cohort Study. J Acquir Immune Defic Syndr 2012; 60:135-42.
Jun 1, 2012Small dense lipoproteins, apolipoprotein B, and risk of coronary events in HIV-infected patients on antiretroviral therapy: the Swiss HIV Cohort Study
Jun 1, 2012J Acquir Immune Defic Syndr 2012; 60:135-42
Bucher Heiner C, Battegay Manuel, Furrer Hansjakob, Weber Rainer, Hirschel Bernard, Vernazza Pietro, Cavassini Matthias, Wang Qing, Magenta Lorenzo, Glass Tracy R, Richter Werner, Bernasconi Enos